Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer.
Svaton M, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Jakubikova L, Cernovska M, Hrnciarik M, Jirousek M, Krejci J, Krejci D, Bilek O, Blazek J, Hurdalkova K, Barinova M, Melichar B. Svaton M, et al. Among authors: jirousek m. Anticancer Res. 2020 Apr;40(4):2209-2217. doi: 10.21873/anticanres.14182. Anticancer Res. 2020. PMID: 32234916
Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry.
Venclicek O, Skrickova J, Brat K, Fischer O, Havel L, Hrnciarik M, Marel M, Opalka P, Krakorova G, Rozsivalova D, Kultan J, Mullerova A, Zarnayova L, Smickova P, Vasakova M, Gyorfy Z, Jirousek M, Krejci D, Krejci J, Zuna P, Svaton M, Hrda K, Duba J, Alahakoon J, Svoboda M, Silar J. Venclicek O, et al. Among authors: jirousek m. Anticancer Res. 2021 Nov;41(11):5549-5556. doi: 10.21873/anticanres.15368. Anticancer Res. 2021. PMID: 34732425
Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study.
Marel M, Chladkova Z, Casas Mendez LF, Venclicek O, Skrickova J, Fischer O, Mullerova A, Havel L, Gyorfy Z, Hrnciarik M, Jirousek M, Krejci J, Krejci D, Buresova M, Alahakoon J, Svoboda M, Svaton M. Marel M, et al. Among authors: jirousek m. Cancer Diagn Progn. 2022 Mar 3;2(2):167-172. doi: 10.21873/cdp.10091. eCollection 2022 Mar-Apr. Cancer Diagn Progn. 2022. PMID: 35399169 Free PMC article.
Responses of synanthropic vegetation to composting facility.
Winkler J, Matsui Y, Filla J, Vykydalová L, Jiroušek M, Vaverková MD. Winkler J, et al. Among authors: jirousek m. Sci Total Environ. 2023 Feb 10;859(Pt 1):160160. doi: 10.1016/j.scitotenv.2022.160160. Epub 2022 Nov 12. Sci Total Environ. 2023. PMID: 36375549
CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice.
Zimmer M, Bista P, Benson EL, Lee DY, Liu F, Picarella D, Vega RB, Vu CB, Yeager M, Ding M, Liang G, Horton JD, Kleemann R, Kooistra T, Morrison MC, Wielinga PY, Milne JC, Jirousek MR, Nichols AJ. Zimmer M, et al. Among authors: jirousek mr. Hepatol Commun. 2017 May 12;1(4):311-325. doi: 10.1002/hep4.1042. eCollection 2017 Jun. Hepatol Commun. 2017. PMID: 29404461 Free PMC article.
A Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult Subjects.
Donovan JM, Zimmer M, Offman E, Grant T, Jirousek M. Donovan JM, et al. Among authors: jirousek m. J Clin Pharmacol. 2017 May;57(5):627-639. doi: 10.1002/jcph.842. Epub 2017 Jan 11. J Clin Pharmacol. 2017. PMID: 28074489 Free PMC article. Clinical Trial.
Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid.
Vu CB, Bemis JE, Benson E, Bista P, Carney D, Fahrner R, Lee D, Liu F, Lonkar P, Milne JC, Nichols AJ, Picarella D, Shoelson A, Smith J, Ting A, Wensley A, Yeager M, Zimmer M, Jirousek MR. Vu CB, et al. Among authors: jirousek mr. J Med Chem. 2016 Feb 11;59(3):1217-31. doi: 10.1021/acs.jmedchem.5b01961. Epub 2016 Feb 1. J Med Chem. 2016. PMID: 26784936
55 results